The First-Ever Treatment for Geographic Atrophy (GA), the Advanced Dry Form of AMD, Has Been Approved by the FDA
Approximately 10 million Americans have Age-Related Macular Degeneration (AMD), including nearly one million with the advanced dry form called Geographic Atrophy (GA). GA slowly robs people of their central vision, and impacts their ability to drive, read, and see faces. While treatment has been available for the wet form of AMD for nearly 20 years, patients with GA have not had a treatment option available, until now.
Schedule a consultation with our doctors today to determine if this is the right treatment for you or your patients.